Your Shopping Cart Is Empty
| Report Code: A12350 | Nov 2021 | Pages: 286 | ||
| Tables: 165 | Charts: 52 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Pharmaceutical Suppositories Market
Request Now !Global pharmaceutical suppositories market was valued at $1,410.93 million in 2020, and is projected to reach $2,402.46 million by 2030, registering a CAGR of 5.7% from 2021 to 2030. Suppositories are solid dosage forms of medication that are precisely designed for insertion into bodily cavities other than the mouth. They can be placed in the rectum, vaginal canal, or urethra. These items are designed to melt or dissolve in the cavity fluids after insertion, allowing the drug to be released. Based on its site of insertion, suppositories are divided into rectal suppository, vaginal suppository, and urethral suppository. Suppositories have usefulness on site action. It omits the first pass effect, which save drug from metabolism.
Suppositories can be used as drug delivering option in case of bitter and obnoxious drugs. In pediatrics, suppositories are often used to treat constipation like symptoms. However, there is a possibility of mucosal irritation at the site of use which may limit its usage.
The growth of the pharmaceutical suppositories market is driven by increase in the geriatric population. In these populations, the rectal route is a great alternative for drug delivery. The increased demand for suppositories is anticipated to enhance the market growth during the forecasted period, due to benefits such as quick absorption of various low molecular weight drugs and the potential for absorption into the lymphatic system. However, low demand in under developed countries restrain the growth of the pharmaceutical suppository market. Conversely, high market growth potential in emerging markets is expected to offer lucrative opportunities during the forecast period.
Coronavirus (COVID-19) was discovered in late December in Hubei province of Wuhan city in China. The disease is caused by a virus, namely, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which is transmitted from humans to humans. The pharmaceutical suppositories manufacture was disturbed in the 2020 due to the slowdown of distribution chain of raw material. Moreover, the manpower needed for the manufacturing plants were made to home quarantine or lockdown which made to shut down of the manufacturing plants of the suppositories. Overall impact of the COVID-19 pandemic on the pharmaceutical suppositories market was recorded to be negative owing to the factors like disturbance in the distribution chain, financial problems, scarcity of labors and increase in the demand and supply gap. However, this situation is expected to change post COVID-19 pandemic in the coming years.
The pharmaceutical suppositories market is segmented on the basis of type, base, distribution channel, end user, and region. By type, the market is divided into rectal suppositories, vaginal suppositories and urethral suppositories. By base, it is classified into fatty base, water miscible bases, and emulsifying bases. The water miscible bases are further segmented into glycero gelatin base, soap glycerin suppositories, and polyethylene glycol bases. The emulsifying bases are further segmented into witepsol, massa esterium, and massuppol. By distribution channel, the market is divided into hospital pharmacies, retail pharmacies, and online sales. By end user, it is classified into hospitals & clinics, home care, and nursing home. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By type, the market is segregated into rectal suppositories, vaginal suppositories and urethral suppositories. The rectal suppository generated the highest revenue in 2020. This is attributed to the increase in focus on the development of rectal suppository. Major factors that influenced the market growth include rise in prevalence of diseases like hemorrhoids and constipation, and rise in investments by rectal suppositories manufacturers. In addition, rise in geriatric population, surge in demand for use of suppositories dosage forms, has further influenced companies to focus on the development of pharmaceutical suppositories.
By base, the market is segregated into fatty base, water miscible bases, and emulsifying bases. The water miscible bases are further segmented into glycero gelatin base, soap glycerin suppositories, and polyethylene glycol bases. The emulsifying bases are further segmented into witepsol, massa esterium, and massuppol. Emulsifying bases the highest revenue in 2020. Major factors that influenced the market growth include rise in demand of emulsifying bases, increase in the number of benefits of emulsifying bases, increase in the use of emulsifying bases formulated suppositories, and increase in the prevalence of diseases that require suppositories which are formulated using emulsifying bases.
By distribution channel, the market is segregated into hospital pharmacies, retail pharmacies and online sales. At present, the hospital pharmacies segment accounts for the majority of market share, owing to rise in prevalence of diseases like hemorrhoids and constipation in both developed as well as developing countries and growing awareness among the population about the importance and benefits of using suppositories.
By end user, the market is segregated into hospitals & clinics, home care, and nursing home. The hospital & clinics segment dominated the global market in 2020 and is anticipated to continue this trend during the forecast period. This was attributed to the fact that hospitals & clinics are increasingly showing an inclination toward pharmaceutical suppositories products. Moreover, surge in geriatric population (as this population is more prone to various chronic diseases), rise in number of government initiatives to ensure high degree chronic disease treatment measures, and surge in number of hospitals with increased use of suppositories therapy boost the growth of the hospitals segment.
North America accounted for the major share in the pharmaceutical suppositories market, owing to increase in well-developed healthcare industry, presence of leading manufacturers in the region, and high adoption rate of suppositories in this region. However, Asia-Pacific is projected to register the fastest growth during the forecast period, owing to increase in number of geriatric population, rise in people suffering from constipation and hemorrhoids, and improving healthcare infrastructure in the region.
Pharmaceutical Suppositories Market Research Study Key Benefits
Key Market Segments
By Type
By BASE
By Distribution Channel
By End User
By Region
Leading Market Players
Pharmaceutical Suppositories Market Report Highlights
| Aspects | Details |
|---|---|
| By Type |
|
| By BASE |
|
| By Distribution Channel |
|
| By End User |
|
| By Region |
|
| Key Market Players | Cadila Healthcare Ltd, Cosette Pharmaceuticals, Inc., Sanofi S.A., Bayer Ag, Intas Pharmaceuticals Ltd., Pfizer Inc., Bliss Gvs Pharma Ltd, Church And Dwight Uk Ltd, Novartis International Ag, Glenmark Pharmaceuticals Limited |
CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key Benefits for Stakeholders
1.3.Key market segments
1.3.1.List of key players profiled in the report
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET LANDSCAPE
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.2.2.Top winning strategies
3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics
3.5.1.Drivers
3.5.1.1.Rise in prevalence of acute & chronic disorders which require the use of suppository
3.5.1.2.Increase in the geriatric population
3.5.1.3.Increase in government expenditure on healthcare
3.5.2.Restraint
3.5.2.1.Low demand in underdeveloped countries
3.5.3.Opportunity
3.5.3.1.High market growth potential in emerging markets
3.5.4.Impact analysis
3.6.COVID-19 Impact Analysis on Pharmaceutical Suppositories Market
3.7.Company Profile of Contract Manufacturers
3.7.1.Aenova Holding GmbH
3.7.1.1.Company overview
3.7.1.2.Company snapshot
3.7.1.3.Operating business segments
3.7.1.4.Product portfolio
3.7.1.5.Business performance
3.7.2.Atral
3.7.2.1.Company overview
3.7.2.2.Company snapshot
3.7.2.3.Operating business segments
3.7.2.4.Product portfolio
3.7.3.Delpharm
3.7.3.1.Company overview
3.7.3.2.Company snapshot
3.7.3.3.Operating business segments
3.7.3.4.Product portfolio
3.7.4.Laboratoires Galéniques Vernin (LGV) Mayoly Spindler
3.7.4.1.Company overview
3.7.4.2.Company snapshot
3.7.4.3.Operating business segments
3.7.4.4.Product portfolio
3.7.5.Priyans Drugs
3.7.5.1.Company overview
3.7.5.2.Company snapshot
3.7.5.3.Operating business segments
3.7.5.4.Product portfolio
3.7.6.Unither Pharmaceuticals
3.7.6.1.Company overview
3.7.6.2.Company snapshot
3.7.6.3.Operating business segments
3.7.6.4.Product portfolio
CHAPTER 4:PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE
4.1.Overview
4.1.1.Market size and forecast
4.2.Rectal Suppositories
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.3.Vaginal Suppositories
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.4.Urethral Suppositories
4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country
CHAPTER 5:PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE
5.1.Overview
5.1.1.Market size and forecast
5.2.Fatty bases
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast, by region
5.2.3.Market analysis, by country
5.3.Water Miscible bases
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast, by region
5.3.3.Market analysis, by country
5.3.4.Market size and forecast, by type
5.3.4.1.Glycero-gelatin base
5.3.4.1.1.Market size and forecast
5.3.4.2.Soap glycerin base
5.3.4.2.1.Market size and forecast
5.3.4.3.Polyethylene glycol bases
5.3.4.3.1.Market size and forecast
5.4.Emulsifying bases
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast, by region
5.4.3.Market analysis, by country
5.4.4.Market size and forecast, by type
5.4.4.1.Witepsol
5.4.4.1.1.Market size and forecast
5.4.4.2.Massa Esterium
5.4.4.2.1.Market size and forecast
5.4.4.3.Massupol
5.4.4.3.1.Market size and forecast
CHAPTER 6:PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospital pharmacies
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast, by region
6.2.3.Market analysis, by country
6.3.Retail pharmacies
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast, by region
6.3.3.Market analysis, by country
6.4.Online sales
6.4.1.Key market trends, growth factors, and opportunities
6.4.2.Market size and forecast, by region
6.4.3.Market analysis, by country
CHAPTER 7:PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER
7.1.Overview
7.1.1.Market size and forecast
7.2.Hospitals & clinics
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by region
7.2.3.Market analysis, by country
7.3.Home care
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by region
7.3.3.Market analysis, by country
7.4.Nursing home
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by region
7.4.3.Market analysis, by country
CHAPTER 8:PHARMACEUTICAL SUPPOSITORIES MARKET, BY REGION
8.1.Overview
8.1.1.Market size and forecast
8.2.North America
8.2.1.Key market trends, growth factors, and opportunities
8.2.2.1.U.S.
8.2.2.1.1.U.S. pharmaceutical suppositories market, by Type
8.2.2.1.2.U.S. pharmaceutical suppositories market, By Base
8.2.2.1.3.U.S. pharmaceutical suppositories market, By Distribution Channel
8.2.2.1.4.U.S. pharmaceutical suppositories market, By End User
8.2.2.2.Canada
8.2.2.2.1.Canada pharmaceutical suppositories market, by Type
8.2.2.2.2.Canada pharmaceutical suppositories market, By Base
8.2.2.2.3.Canada pharmaceutical suppositories market, By Distribution Channel
8.2.2.2.4.Canada pharmaceutical suppositories market, By End User
8.2.2.3.Mexico
8.2.2.3.1.Mexico pharmaceutical suppositories market, by Type
8.2.2.3.2.Mexico pharmaceutical suppositories market, By Base
8.2.2.3.3.Mexico pharmaceutical suppositories market, By Distribution Channel
8.2.2.3.4.Mexico pharmaceutical suppositories market, By End User
8.2.3.North America market size and forecast, by Type
8.2.4.North America market size and forecast, By Base
8.2.5.North America market size and forecast, By Distribution Channel
8.2.6.North America market size and forecast, By End User
8.3.Europe
8.3.1.Key market trends, growth factors, and opportunities
8.3.2.Market size and forecast, by country
8.3.2.1.Germany
8.3.2.1.1.Germany pharmaceutical suppositories market, by Type
8.3.2.1.2.Germany pharmaceutical suppositories market, By Base
8.3.2.1.3.Germany pharmaceutical suppositories market, By Distribution Channel
8.3.2.1.4.Germany pharmaceutical suppositories market, By End User
8.3.2.2.France
8.3.2.2.1.France pharmaceutical suppositories market, by Type
8.3.2.2.2.France pharmaceutical suppositories market, By Base
8.3.2.2.3.France pharmaceutical suppositories market, By Distribution Channel
8.3.2.2.4.France pharmaceutical suppositories market, By End User
8.3.2.3.UK
8.3.2.3.1.UK pharmaceutical suppositories market, by Type
8.3.2.3.2.UK pharmaceutical suppositories market, By Base
8.3.2.3.3.UK pharmaceutical suppositories market, By Distribution Channel
8.3.2.3.4.UK pharmaceutical suppositories market, By End User
8.3.2.4.Italy
8.3.2.4.1.Italy pharmaceutical suppositories market, by Type
8.3.2.4.2.Italy pharmaceutical suppositories market, By Base
8.3.2.4.3.Italy pharmaceutical suppositories market, By Distribution Channel
8.3.2.4.4.Italy pharmaceutical suppositories market, By End User
8.3.2.5.Spain
8.3.2.5.1.Spain pharmaceutical suppositories market, by Type
8.3.2.5.2.Spain pharmaceutical suppositories market, By Base
8.3.2.5.3.Spain pharmaceutical suppositories market, By Distribution Channel
8.3.2.5.4.Spain pharmaceutical suppositories market, By End User
8.3.2.6.Rest of Europe
8.3.2.6.1.Rest of Europe pharmaceutical suppositories market, by Type
8.3.2.6.2.Rest of Europe pharmaceutical suppositories market, By Base
8.3.2.6.3.Rest of Europe pharmaceutical suppositories market, By Distribution Channel
8.3.2.6.4.Rest of Europe pharmaceutical suppositories market, By End User
8.3.3.Europe market size and forecast, by Type
8.3.4.Europe market size and forecast, By Base
8.3.5.Europe market size and forecast, By Distribution Channel
8.3.6.Europe market size and forecast, By End User
8.4.Asia-Pacific
8.4.1.Key market trends, growth factors, and opportunities
8.4.2.Market size and forecast, by country
8.4.2.1.Japan
8.4.2.1.1.Japan pharmaceutical suppositories market, by Type
8.4.2.1.2.Japan pharmaceutical suppositories market, By Base
8.4.2.1.3.Japan pharmaceutical suppositories market, By Distribution Channel
8.4.2.1.4.Japan pharmaceutical suppositories market, By End User
8.4.2.2.China
8.4.2.2.1.China pharmaceutical suppositories market, by Type
8.4.2.2.2.China pharmaceutical suppositories market, By Base
8.4.2.2.3.China pharmaceutical suppositories market, By Distribution Channel
8.4.2.2.4.China pharmaceutical suppositories market, By End User
8.4.2.3.Australia
8.4.2.3.1.Australia pharmaceutical suppositories market, by Type
8.4.2.3.2.Australia pharmaceutical suppositories market, By Base
8.4.2.3.3.Australia pharmaceutical suppositories market, By Distribution Channel
8.4.2.3.4.Australia pharmaceutical suppositories market, By End User
8.4.2.4.India
8.4.2.4.1.India pharmaceutical suppositories market, by Type
8.4.2.4.2.India pharmaceutical suppositories market, By Base
8.4.2.4.3.India pharmaceutical suppositories market, By Distribution Channel
8.4.2.4.4.India pharmaceutical suppositories market, By End User
8.4.2.5.South Korea
8.4.2.5.1.South Korea pharmaceutical suppositories market, by Type
8.4.2.5.2.South Korea pharmaceutical suppositories market, By Base
8.4.2.5.3.South Korea pharmaceutical suppositories market, By Distribution Channel
8.4.2.5.4.South Korea pharmaceutical suppositories market, By End User
8.4.2.6.Rest of Asia-Pacific
8.4.2.6.1.Rest of Asia-Pacific pharmaceutical suppositories market, by Type
8.4.2.6.2.Rest of Asia-Pacific pharmaceutical suppositories market, By Base
8.4.2.6.3.Rest of Asia-Pacific pharmaceutical suppositories market, By Distribution Channel
8.4.2.6.4.Rest of Asia-Pacific pharmaceutical suppositories market, By End User
8.4.3.Asia-Pacific market size and forecast, by Type
8.4.4.Asia-Pacific market size and forecast, By Base
8.4.5.Asia-Pacific market size and forecast, By Distribution Channel
8.4.6.Asia-Pacific market size and forecast, By End User
8.5.LAMEA
8.5.1.Key market trends, growth factors, and opportunities
8.5.2.Market size and forecast, by country
8.5.2.1.Brazil
8.5.2.1.1.Brazil pharmaceutical suppositories market, By Type
8.5.2.1.2.Brazil pharmaceutical suppositories market, By Base
8.5.2.1.3.Brazil pharmaceutical suppositories market, By Distribution Channel
8.5.2.1.4.Brazil pharmaceutical suppositories market, By End User
8.5.2.2.Saudi Arabia
8.5.2.2.1.Saudi Arabia pharmaceutical suppositories market, By Type
8.5.2.2.2.Saudi Arabia pharmaceutical suppositories market, By Base
8.5.2.2.3.Saudi Arabia pharmaceutical suppositories market, By Distribution Channel
8.5.2.2.4.Saudi Arabia pharmaceutical suppositories market, By End User
8.5.2.3.South Africa
8.5.2.3.1.South Africa pharmaceutical suppositories market, By Type
8.5.2.3.2.South Africa pharmaceutical suppositories market, By Base
8.5.2.3.3.South Africa pharmaceutical suppositories market, By Distribution Channel
8.5.2.3.4.South Africa pharmaceutical suppositories market, By End User
8.5.2.4.Rest of LAMEA
8.5.2.4.1.Rest of LAMEA pharmaceutical suppositories market, By Type
8.5.2.4.2.Rest of LAMEA pharmaceutical suppositories market, By Base
8.5.2.4.3.Rest of LAMEA pharmaceutical suppositories market, By Distribution Channel
8.5.2.4.4.Rest of LAMEA pharmaceutical suppositories market, By End User
8.5.3.LAMEA market size and forecast, By Type
8.5.4.LAMEA market size and forecast, By Base
8.5.5.LAMEA market size and forecast, By Distribution Channel
8.5.6.LAMEA market size and forecast, By End User
CHAPTER 9:COMPANY PROFILES
9.1.BAYER AG
9.1.1.Company overview
9.1.2.Company snapshot
9.1.3.Operating business segments
9.1.4.Product portfolio
9.1.5.Business performance
9.2.BLISS GVS PHARMA LTD.
9.2.1.Company overview
9.2.2.Company snapshot
9.2.3.Operating business segments
9.2.4.Product portfolio
9.2.5.Business performance
9.3.CADILA HEALTHCARE LTD
9.3.1.Company overview
9.3.2.Company snapshot
9.3.3.Operating business segments
9.3.4.Product portfolio
9.3.5.Business performance
9.3.6.Key strategic moves and developments
9.4.CHURCH & DWIGHT CO., INC.
9.4.1.Company overview
9.4.2.Company snapshot
9.4.3.Operating business segments
9.4.4.Product portfolio
9.4.5.Business performance
9.5.COSETTE PHARMACEUTICALS, INC.
9.5.1.Company overview
9.5.2.Company snapshot
9.5.3.Operating business segments
9.5.4.Product portfolio
9.5.5.Key strategic moves and developments
9.6.GLENMARK PHARMACEUTICALS LTD.
9.6.1.Company overview
9.6.2.Company snapshot
9.6.3.Operating business segments
9.6.4.Product portfolio
9.6.5.Business performance
9.7.INTAS PHARMACEUTICALS LTD.
9.7.1.Company overview
9.7.2.Company snapshot
9.7.3.Operating business segments
9.7.4.Product portfolio
9.8.NOVARTIS INTERNATIONAL AG
9.8.1.Company overview
9.8.2.Company snapshot
9.8.3.Operating business segments
9.8.4.Product portfolio
9.8.5.Business performance
9.9.PFIZER, INC.
9.9.1.Company overview
9.9.2.Company snapshot
9.9.3.Operating business segments
9.9.4.Product portfolio
9.9.5.Business performance
9.10.SANOFI S.A.
9.10.1.Company overview
9.10.2.Company snapshot
9.10.3.Operating business segments
9.10.4.Product portfolio
9.10.5.Business performance
LIST OF TABLES
TABLE 01.AENOVA HOLDINGS: COMPANY SNAPSHOT
TABLE 02.AENOVA HOLDINGS: OPERATING SEGMENTS
TABLE 03.AENOVA HOLDINGS: PRODUCT PORTFOLIO
TABLE 04.ATRAL: COMPANY SNAPSHOT
TABLE 05.ATRAL: OPERATING SEGMENTS
TABLE 06.ATRAL: PRODUCT PORTFOLIO
TABLE 07.DELPHARM: COMPANY SNAPSHOT
TABLE 08.DELPHARM: OERATING SEGMENT
TABLE 09.DELPHARM: PRODUCT PORTFOLIO
TABLE 10.LGV MAYOLY SPINDLER: COMPANY SNAPSHOT
TABLE 11.LGV MAYOLY SPINDLER: OPERATING SEGMENTS
TABLE 12.LGV MAYOLY SPINDLER: PRODUCT PORTFOLIO
TABLE 13.PRIYANS DRUGS: COMPANY SNAPSHOT
TABLE 14.PRIYANS DRUGS: OERATING SEGMENT
TABLE 15.PRIYANS DRUGS: PRODUCT PORTFOLIO
TABLE 16.UNITHER: COMPANY SNAPSHOT
TABLE 17.UNITHER: OPERATING SEGMENTS
TABLE 18.UNITHER: PRODUCT PORTFOLIO
TABLE 19.PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020-2030 ($MILLION)
TABLE 20.PHARMACEUTICAL SUPPOSITORIES MARKET FOR RECTAL SUPPOSITORIES, BY REGION, 2020-2030 ($MILLION)
TABLE 21.VAGINAL SUPPOSITORIES PHARMACEUTICAL SUPPOSITORIES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 22.URETHRAL SUPPOSITORIES PHARMACEUTICAL SUPPOSITORIES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 23.PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASES, 2020-2030 ($MILLION)
TABLE 24.PHARMACEUTICAL SUPPOSITORIES MARKET FOR FATTY BASES, BY REGION, 2020-2030 ($MILLION)
TABLE 25.PHARMACEUTICAL SUPPOSITORIES MARKET FOR WATER MISCIBLE BASES, BY REGION, 2020-2030 ($MILLION)
TABLE 26.PHARMACEUTICAL SUPPOSITORIES MARKET FOR WATER MISCIBLE BASES, BY TYPE, 2020–2030 ($MILLION)
TABLE 27.URETHRAL SUPPOSITORIES PHARMACEUTICAL SUPPOSITORIES MARKET, BY REGION, 2020-2030 ($MILLION)
TABLE 28.PHARMACEUTICAL SUPPOSITORIES MARKET FOR EMULSIFYING BASES, BY TYPE, 2020–2030 ($MILLION)
TABLE 29.PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020-2030 ($MILLION)
TABLE 30.PHARMACEUTICAL SUPPOSITORIES MARKET FOR HOSPITAL PHARMACIES, BY REGION, 2020-2030 ($MILLION)
TABLE 31.PHARMACEUTICAL SUPPOSITORIES MARKET FOR RETAIL PHARMACIES, BY REGION, 2020-2030 ($MILLION)
TABLE 32.PHARMACEUTICAL SUPPOSITORIES MARKET FOR ONLINE SALES, BY REGION, 2020-2030 ($MILLION)
TABLE 33.PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 34.PHARMACEUTICAL SUPPOSITORIES MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2020-2030 ($MILLION)
TABLE 35.PHARMACEUTICAL SUPPOSITORIES MARKET FOR HOME CARE, BY REGION, 2020-2030 ($MILLION)
TABLE 36.PHARMACEUTICAL SUPPOSITORIES MARKET FOR NURSING HOME, BY REGION, 2020-2030 ($MILLION)
TABLE 37.PHARMACEUTICAL SUPPOSITORIES MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 38.NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 39.U.S. PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 40.U.S. PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 41.U.S. PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 42.U.S. PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 43.CANADA PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 44.CANADA PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 45.CANADA PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 46.CANADA PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 47.MEXICO PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 48.MEXICO PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 49.MEXICO PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 50.MEXICO PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 51.NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 52.NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 53.NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 54.NORTH AMERICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 55.EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 56.GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 57.GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 58.GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 59.GERMANY PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 60.FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 61.FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 62.FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 63.FRANCE PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 64.UK PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 65.UK PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 66.UK PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 67.UK PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 68.ITALY PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 69.ITALY PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 70.ITALY PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 71.ITALY PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 72.SPAIN PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 73.SPAIN PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 74.SPAIN PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 75.SPAIN PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 76.REST OF EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 77.REST OF EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 78.REST OF EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 79.REST OF EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 80.EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 81.EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 82.EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 83.EUROPE PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 84.ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 85.JAPAN PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 86.JAPAN PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 87.JAPAN PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 88.JAPAN PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 89.CHINA PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 90.CHINA PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 91.CHINA PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 92.CHINA PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 93.AUSTRALIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 94.AUSTRALIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 95.AUSTRALIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 96.AUSTRALIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 97.INDIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 98.INDIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 99.INDIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 100.INDIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 101.SOUTH KOREA PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 102.SOUTH KOREA PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 103.SOUTH KOREA PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 104.SOUTH KOREA PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 105.REST OF ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 106.REST OF ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 107.REST OF ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 108.REST OF ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 109.ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 110.ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 111.ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 112.ASIA-PACIFIC PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 113.LAMEA PHARMACEUTICAL SUPPOSITORIES MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 114.BRAZIL PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 115.BRAZIL PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 116.BRAZIL PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 117.BRAZIL PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 118.SAUDI ARABIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 119.SAUDI ARABIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 120.SAUDI ARABIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 121.SAUDI ARABIA PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 122.SOUTH AFRICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 123.SOUTH AFRICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 124.SOUTH AFRICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 125.SOUTH AFRICA PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 126.REST OF LAMEA PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 127.REST OF LAMEA PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 128.REST OF LAMEA PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 129.REST OF LAMEA PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 130.LAMEA PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE, 2020–2030 ($MILLION)
TABLE 131.LAMEA PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE, 2020–2030 ($MILLION)
TABLE 132.LAMEA PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 133.LAMEA PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 134.BAYER: COMPANY SNAPSHOT
TABLE 135.BAYER: OPERATING SEGMENTS
TABLE 136.BAYER: PRODUCT PORTFOLIO
TABLE 137.BLISS GVS: COMPANY SNAPSHOT
TABLE 138.BLISS GVS: OPERATING SEGMENTS
TABLE 139.BLISS GVS: PRODUCT PORTFOLIO
TABLE 140.ZYDUS CADILA: COMPANY SNAPSHOT
TABLE 141.ZYDUS CADILA: OPERATING SEGMENTS
TABLE 142.ZYDUS CADILA: PRODUCT PORTFOLIO
TABLE 143.ZYDUS CADILA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 144.CHURCH & DWIGHT: COMPANY SNAPSHOT
TABLE 145.CHURCH & DWIGHT.: OPERATING SEGMENTS
TABLE 146.CHURCH & DWIGHT: PRODUCT PORTFOLIO
TABLE 147.COSETTE PHARMACEUTICALS: COMPANY SNAPSHOT
TABLE 148.COSETTE PHARMACEUTICALS: OPERATING SEGMENTS
TABLE 149.COSETTE PHARMACEUTICALS: PRODUCT PORTFOLIO
TABLE 150.COSETTE PHARMACEUTICALS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 151.GLENMARK: COMPANY SNAPSHOT
TABLE 152.GLENMARK: OERATING SEGMENT
TABLE 153.GLENMARK: PRODUCT PORTFOLIO
TABLE 154.INTAS PHARMA: COMPANY SNAPSHOT
TABLE 155.INTAS PHARMA: OPERATING SEGMENTS
TABLE 156.INTAS PHARMA: PRODUCT PORTFOLIO
TABLE 157.NOVARTIS: COMPANY SNAPSHOT
TABLE 158.NOVARTIS: OERATING SEGMENT
TABLE 159.NOVARTIS: PRODUCT PORTFOLIO
TABLE 160.PFIZER: COMPANY SNAPSHOT
TABLE 161.PFIZER: OPERATING SEGMENT
TABLE 162.PFIZER: PRODUCT TYPE PORTFOLIO
TABLE 163.SANOFI: COMPANY SNAPSHOT
TABLE 164.SANOFI: OERATING SEGMENT
TABLE 165.SANOFI: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01.GLOBAL PHARMACEUTICAL SUPPOSITORIES MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018-2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.MODERATE BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.AENOVA HOLDINGS: NET SALES, 2018–2020 ($MILLION)
FIGURE 14.AENOVA HOLDINGS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 15.AENOVA HOLDINGS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF PHARMACEUTICAL SUPPOSITORIES MARKET FOR RECTAL SUPPOSITORIES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF VAGINAL SUPPOSITORIES PHARMACEUTICAL SUPPOSITORIES MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF URETHRAL SUPPOSITORIES PHARMACEUTICAL SUPPOSITORIES MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF PHARMACEUTICAL SUPPOSITORIES MARKET FOR FATTY BASES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF PHARMACEUTICAL SUPPOSITORIES MARKET FOR WATER MISCIBLE BASES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21.GLYCERO-GELATIN BASE PHARMACEUTICAL SUPPOSITORIES MARKET, 2020–2030 ($MILLION)
FIGURE 22.SOAP GLYCERIN BASE PHARMACEUTICAL SUPPOSITORIES MARKET, 2020–2030 ($MILLION)
FIGURE 23.POLYETHYLENE GLYCOL PHARMACEUTICAL SUPPOSITORIES MARKET, 2020–2030 ($MILLION)
FIGURE 24.COMPARATIVE ANALYSIS OF PHARMACEUTICAL SUPPOSITORIES MARKET FOR EMULSIFYING BASES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 25.WITEPSOL PHARMACEUTICAL SUPPOSITORIES MARKET, 2020–2030 ($MILLION)
FIGURE 26.MASSA ESTERIUM PHARMACEUTICAL SUPOSITORIES MARKET, 2020–2030 ($MILLION)
FIGURE 27.MASSUPOL PHARMACEUTICAL SUPPOSITORIES MARKET, 2020–2030 ($MILLION)
FIGURE 28.COMPARATIVE ANALYSIS OF PHARMACEUTICAL SUPPOSITORIES MARKET HOSPITAL PHARMACIES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 29.PHARMACEUTICAL SUPPOSITORIES MARKET FOR RETAIL PHARMACIES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 30.COMPARATIVE ANALYSIS OF PHARMACEUTICAL SUPPOSITORIES MARKET FOR ONLINE SALES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 31.COMPARATIVE ANALYSIS OF PHARMACEUTICAL SUPPOSITORIES MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 32.COMPARATIVE ANALYSIS OF PHARMACEUTICAL SUPPOSITORIES MARKET FOR HOME CARE, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 33.COMPARATIVE ANALYSIS OF PHARMACEUTICAL SUPPOSITORIES MARKET FOR NURSING HOME, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 34.BAYER: NET SALES, 2018–2020 ($MILLION)
FIGURE 35.BAYER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 36.BAYER: REVENUE SHARE BY REGION, 2020(%)
FIGURE 37.BLISS GVS: NET SALES, 2019–2021 ($MILLION)
FIGURE 38.ZYDUS CADILA: NET SALES, 2019–2021 ($MILLION)
FIGURE 39.ZYDUS CADILA: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 40.ZYDUS CADILA: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 41.CHURCH & DWIGHT: NET SALES, 2018–2020 ($MILLION)
FIGURE 42.CHURCH & DWIGHT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 43.GLENMARK: NET SALES, 2019–2021 ($MILLION)
FIGURE 44.GLENMARK: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 45.NOVARTIS: NET SALES, 2018–2020 ($MILLION)
FIGURE 46.NOVARTIS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 47.NOVARTIS: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 48.PFIZER: REVENUE, 2018–2020 ($MILLION)
FIGURE 49.PFIZER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 50.SANOFI: NET SALES, 2018–2020 ($MILLION)
FIGURE 51.SANOFI: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 52.SANOFI: REVENUE SHARE BY REGION, 2020 (%)
Pharmaceutical suppositories are solid dosage form which is inserted in body cavities other than mouth. Suppositories provide great alternative of drug delivery and can be useful in case of unconscious patients or where direct on-site action are desired.
The factors such as increased geriatric population, rise in number of gastro-intestinal diseases across the globe, rise in intra uterine diseases and rise in number of hospitals & clinics are expected to drive the growth of the pharmaceutical suppositories market. Moreover, increase in use of rectal suppositories further boost the growth of the market. However, lack of patient acceptability and willingness for suppositories hamper the market growth.
A. The total market value of pharmaceutical suppositories market is $2,402.46 million in 2030.
A. The forcast period for pharmaceutical suppositories market is 2020 to 2030
A. The market value of pharmaceutical suppositories market in 2020 is $1,410.93 million.
A. The base year is 2020 in pharmaceutical suppositories market
A. Top companies such as Pfizer Inc., Sanofi S.A., Bayer AG, Novartis International AG, Cosette Pharmaceuticals, Inc., Church & Dwight Co. Inc., and Bliss GVS Pharma Ltd held a high market position in 2020. These key players held a high market postion owing to the strong geographical foothold in different regions.
A. Rectal suppositories segment is the most influencing segment owing to rise in prevalence of diseases like hemorrhoids and constipation, and rise in investments by rectal suppositories manufacturers. In addition, rise in geriatric population, surge in demand for use of suppositories dosage forms, has further influenced companies to focus on the development of pharmaceutical suppositories.
A. New product launch and product approval are the key trends in the pharmaceutical suppositories market report
A. North America has the highest growth rate of 5.2% in the market which is growing due to increase in well-developed healthcare industry, presence of leading manufacturers in the region, and high adoption rate of suppositories in this region.
A. Yes, the pharmaceutical suppositories market companies are profiled in the report.
A. Yes, the pharmaceutical suppositories market report provides PORTER Analysis
Start reading instantly.
This Report and over 67,068+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report